BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,167,700 | -26.1% | 48,553 | -1.9% | 0.00% | 0.0% |
| Q2 2023 | $1,581,014 | -0.8% | 49,515 | -4.9% | 0.00% | -20.0% |
| Q1 2023 | $1,593,495 | -27.8% | 52,041 | -7.8% | 0.01% | -28.6% |
| Q4 2022 | $2,206,508 | -18.4% | 56,418 | -0.6% | 0.01% | -22.2% |
| Q3 2022 | $2,705,000 | +16.4% | 56,786 | -5.4% | 0.01% | +50.0% |
| Q2 2022 | $2,324,000 | -39.3% | 60,047 | -10.1% | 0.01% | -25.0% |
| Q1 2022 | $3,828,000 | -28.1% | 66,800 | 0.0% | 0.01% | -20.0% |
| Q4 2021 | $5,323,000 | +0.6% | 66,800 | +9.9% | 0.01% | -9.1% |
| Q3 2021 | $5,290,000 | -36.8% | 60,800 | -6.5% | 0.01% | -35.3% |
| Q2 2021 | $8,370,000 | +83.2% | 65,030 | +13.9% | 0.02% | +70.0% |
| Q1 2021 | $4,570,000 | +0.9% | 57,100 | +2.9% | 0.01% | 0.0% |
| Q4 2020 | $4,531,000 | +868.2% | 55,500 | +192.1% | 0.01% | +900.0% |
| Q3 2020 | $468,000 | -12.0% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $532,000 | +55.6% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $342,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |